Novo Nordisk A-S

Yahoo Finance • 15 hours ago

Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Stocks All Popped Today

Bad news for Pfizer (NYSE: PFE) turned into good news for Eli Lilly (NYSE: LLY), Novo Nordisk(NYSE: NVO), and Viking Therapeutics(NASDAQ: VKTX) Monday morning, each of which is rising on Pfizer's latest product announcement. Early this mo... Full story

Yahoo Finance • 6 days ago

Delta, Walmart, pharmaceutical stocks: Market Minute

Catalysts host Madison Mills goes over some of the top stories of the day on this segment of Market Minute. Delta Air Lines (DAL) cut its full-year guidance as uncertainty around tariffs weighs on bookings. Walmart (WMT) walks back its f... Full story

Yahoo Finance • 6 days ago

5 Top Growth Stocks to Buy in the Stock Market Sell-Off

Equity markets may be struggling because of President Donald Trump's current economic policies, but that doesn't mean investors should avoid buying stocks right now -- quite the contrary. History tells us that equities tend to experience s... Full story

Yahoo Finance • 10 days ago

Eli Lilly, Novo Stocks Dive After Medicare Excludes Weight-Loss Drugs

The Trump administration finalized new Medicare and Medicaid policies late Friday, but left out weight-loss drugs. Eli Lilly stock skidded. Continue Reading View Comments... Full story

Yahoo Finance • 19 days ago

1 Growth Stock Down 40% to Buy and Hold Forever

This might surprise some, but Danish pharmaceutical giant Novo Nordisk(NYSE: NVO) has significantly lagged the market in the past year. The drugmaker's shares are down by 40% over the trailing-12-month period, despite grabbing headlines fo... Full story

Yahoo Finance • 21 days ago

Ozempic Maker Novo Nordisk Is No Longer Europe’s Most Valuable Stock. How SAP Took the Crown.

The two stocks have been trending in different directions for months. Here's what that says about the broader market. Continue Reading View Comments... Full story

Yahoo Finance • 21 days ago

Is Novo Nordisk A/S (NYSE:NVO) The Best Extremely Profitable Stocks to Buy According to Analyst?

We recently published a list of 11 Best Extremely Profitable Stocks to Buy According to Analysts. In this article, we are going to take a look at where Novo Nordisk A/S (NYSE:NVO) stands against other best extremely profitable stocks to bu... Full story

Yahoo Finance • 21 days ago

Novo Nordisk A/S Investors: Please contact the Portnoy Law Firm to recover your losses; March 25, 2025 Deadline to file Lead Plaintiff Motion

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, March 24, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Novo Nordisk A/S ("Novo Nordisk" or the "Company") (NYSE: NVO) invest... Full story

Yahoo Finance • 22 days ago

Novo Nordisk A/S Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky Before March 25, 2025 to Discuss Your Rights – NVO

NEW YORK, March 24, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Novo Nordisk A/S ("Novo" or the "Company") (NYSE: NVO) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses... Full story

Yahoo Finance • 22 days ago

NVO DEADLINE ALERT: Novo Nordisk (NVO) Investors with Losses Encouraged to Contact Hagens Berman Before Mar. 25th Deadline in Securities Class Action

SAN FRANCISCO, March 24, 2025 (GLOBE NEWSWIRE) -- Novo Nordisk A/S (NYSE: NVO) is facing a class-action lawsuit from investors who allege the pharmaceutical giant misled them about the prospects of its experimental obesity drug, CagriSem... Full story

Yahoo Finance • 22 days ago

Why Novo Nordisk Stock Dropped on Monday, but Eli Lilly and Him & Hers Health Popped

Novo Nordisk (NYSE: NVO) stock slipped 1.7% through 12:10 a.m. ET Monday on a pair of news items with which investors seem less than thrilled: First, Novo Nordisk is expanding its program to sell Wegovy GLP-1 weight loss drugs at discount... Full story

Yahoo Finance • 22 days ago

SAP Topples Novo to Become Europe’s Biggest Listed Company

(Bloomberg) -- German software developer SAP SE unseated Danish weight-loss drug maker Novo Nordisk A/S as Europe’s most-valuable public company. Most Read from Bloomberg They Built a Secret Apartment in a Mall. Now the Mall Is Dying. Ch... Full story

Yahoo Finance • 22 days ago

Germany's SAP overtakes Novo Nordisk as Europe's largest company

LONDON (Reuters) - German software company SAP overtook Danish healthcare company Novo Nordisk as Europe's largest company by market cap on Monday. At 0900 GMT, SAP had a market cap of $340 billion, slightly more than Novo Nordisk, accord... Full story

Yahoo Finance • 22 days ago

NVO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Novo Nordisk A/S Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

NEW YORK, March 23, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Novo Nordisk A/S (“Novo Nordis... Full story

Yahoo Finance • 22 days ago

NVO FINAL DEADLINE: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Novo Nordisk A/S Investors to Secure Counsel Before Important March 25 Deadline in Securities Class Action – NVO

NEW YORK, March 23, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Novo Nordisk A/S (NYSE: NVO) between November 2, 2022 and December 19, 2024, both dates inclusive (... Full story

Yahoo Finance • 23 days ago

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Novo Nordisk

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Novo Nordisk To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000... Full story

Yahoo Finance • 24 days ago

Novo Nordisk (NVO) Faces Securities Class Action After Weight Loss Therapy Trial Data Disappoints, Analyst Questions Trial’s Design – Hagens Berman

SAN FRANCISCO, March 22, 2025 (GLOBE NEWSWIRE) -- Novo Nordisk A/S (NYSE: NVO) is facing a class-action lawsuit from investors who allege the pharmaceutical giant misled them about the prospects of its experimental obesity drug, CagriSem... Full story

Yahoo Finance • 25 days ago

Levi & Korsinsky Reminds Novo Nordisk A/S Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 25, 2025 – NVO

NEW YORK, March 21, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Novo Nordisk A/S ("Novo" or the "Company") (NYSE: NVO) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses... Full story

Yahoo Finance • 25 days ago

Lowey Dannenberg Notifies Novo Nordisk A/S (“Novo” or the “Company”) (NYSE: NVO) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $200,000 in Losses to Contact the Firm

NEW YORK, March 21, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against Novo Nordisk A/S (“Novo” or the “Company”)... Full story

Yahoo Finance • 25 days ago

התראת מועד אחרון לתביעה נגד NVO: רוזן, יועץ למשקיעים גלובלי, מעודד את משקיעי Novo Nordisk A/S עם הפסדים של יותר מ-100 אלף דולר להבטיח ייעוץ לפני המועד האחרון החשוב בתביעה ייצוגית בניירות ערך – NVO

ניו יורק, March 21, 2025 (GLOBE NEWSWIRE) -- מדוע: משרד רוזן עורכי דין(Rosen Law Firm), משרד עורכי דין בינלאומי העוסק בזכויות משקיעים, מזכיר לרוכשים את ניירות הערך של Novo Nordisk A/S (NYSE: NVO)בין התאריכים 2בנובמבר2022 עד 19בדצמבר 202... Full story